Accessibility Menu
 
Prenetics Global logo

Prenetics Global

(NASDAQ) PRE

Current Price$19.81
Market Cap$335.73M
Since IPO (2021)-83%
5 YearN/A
1 Year+399%
1 Month+18%

Prenetics Global Financials at a Glance

Market Cap

$335.73M

Revenue (TTM)

$95.11M

Net Income (TTM)

$58.32M

EPS (TTM)

$-4.11

P/E Ratio

-4.85

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$19.81

Volume

160,064.95

Open

$20.64

Previous Close

$19.95

Daily Range

$19.45 - $20.67

52-Week Range

$3.09 - $23.63

PRE News

PRE: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Prenetics Global

Industry

Healthcare Providers and Services

Employees

285

CEO

Sheng Wu Yeung

Headquarters

Quarry Bay, HK

PRE Financials

Key Financial Metrics (TTM)

Gross Margin

53%

Operating Margin

-41%

Net Income Margin

-61%

Return on Equity

-31%

Return on Capital

-22%

Return on Assets

-29%

Earnings Yield

-20.62%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$335.73M

Shares Outstanding

16.83M

Volume

160.06K

Short Interest

0.00%

Avg. Volume

261.08K

Financials (TTM)

Gross Profit

$48.94M

Operating Income

$37.38M

EBITDA

$33.60M

Operating Cash Flow

$21.81M

Capital Expenditure

$208.00K

Free Cash Flow

$22.02M

Cash & ST Invst.

$61.49M

Total Debt

$2.20M

Prenetics Global Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$36.56M

+248.6%

Gross Profit

$21.74M

+457.2%

Gross Margin

59.47%

N/A

Market Cap

$335.73M

N/A

Market Cap/Employee

$1.18M

N/A

Employees

285

N/A

Net Income

$28.11M

-72.0%

EBITDA

$12.39M

+50.2%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$59.28M

+3.9%

Accounts Receivable

$2.98M

-46.8%

Inventory

$7.06M

+7.5%

Long Term Debt

$874.00K

-71.0%

Short Term Debt

$1.33M

-51.8%

Return on Assets

-28.66%

N/A

Return on Invested Capital

-22.32%

N/A

Free Cash Flow

$22.02M

N/A

Operating Cash Flow

$21.81M

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ARMPArmata Pharmaceuticals, Inc.
$8.59+2.63%
ATLNAtlantic International Corp.
$3.05-4.69%
OSUROraSure Technologies, Inc.
$2.92-2.67%
PROFProfound Medical Corp.
$5.95-3.88%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$8.52+0.03%
TQQQProShares Trust - ProShares UltraPro Qqq
$37.89-0.02%
INTCIntel
$41.19-0.04%
ONDSOndas
$8.15-0.07%

Questions About PRE

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.